companydata.dkcompanydata.dk

Nordic Pharma Consulting ApS: Financial statements 2022

CVR: 37368598

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Nordic Pharma Consulting ApS (CVR 37368598) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 11,622,261 and a net result of DKK 3,594,582 compared with DKK 1,820,384 the year before. That is an increase of 31.5% compared with the year before. Equity in the 2022 report amounted to DKK 4,397,179. The solvency ratio was 43.2%. The company had 6 employees in the financial year.

Gross Profit
DKK 11,622,261
Profit/Loss
DKK 3,594,582
Equity
DKK 4,397,179
Total Assets
DKK 10,180,057
Employees
6

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-11.6M3.6M4.4M6
2021-8.8M1.8M2.6M6
2020-8.9M1.5M2.3M5
2019-8.6M752K803K-
2018-7M493K748K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Nordic Pharma Consulting ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Nordic Pharma Consulting ApS: The 2021 annual report is outApr 19, 2022

Nordic Pharma Consulting ApS has published its annual report for 2021. Gross profit came to DKK 8,840,664, and the net result was DKK 1,820,384.

Nordic Pharma Consulting ApS appoints new auditorFeb 28, 2022

As of February 28, 2022, 18. juni 2024 P/S has been appointed auditor of Nordic Pharma Consulting ApS.

About Nordic Pharma Consulting ApS

Nordic Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2016. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Bill Madsen and Ray David Sossna. The company is owned by Bill Holding ApS and by.david ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 15,902,080 and a net result of DKK 3,684,788 compared with DKK 2,966,376 the year before. Equity in the 2025 report amounted to DKK 4,487,385.

Source: annual report 2025, Danish Business Authority